FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition 
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids 
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure 
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand 
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid 
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals 
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content 
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026 
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability 
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
SAN FRANCISCO, March 21, 2017 -- Hagens Berman Sobol Shapiro LLP updates investors in AmTrust Financial Services Inc. (NASDAQ:AFSI). The expanded class period is March 2, 2015 through March 16, 2017. The Lead Plaintiff deadline is May 1, 2017.
If you purchased or otherwise acquired securities of AFSI between March 2, 2015 and March 16, 2017 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/AFSI
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
On February 27, 2017 AmTrust disclosed it would not timely file its 2016 annual financial statements. The Company explained it “identified material weaknesses in its internal control over financial reporting that existed as of December 31, 2016, specifically related to ineffective assessment of the risks associated with the financial reporting, and an insufficient complement of corporate accounting and corporate financial reporting resources within the organization.”
This news drove the price of AmTrust shares down over 15% during intraday trading on February 27, 2017.
On March 16, 2017, the Company disclosed it is restating certain historical financial statements and related disclosures to correct improperly recognized revenue and improperly expensed bonuses. In response, the price of AmTrust shares fell over 18% to close at $17.58 on March 17, 2017.
“GAAP violations are serious matters. We’re concerned about the recently admitted accounting irregularities requiring the restatements and the damage inflicted on AFSI investors,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding AmTrust should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000
